-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$62.0083% Upside
Tarsus Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. has been rated by research analysts at Oppenheimer, H.C. Wainwright in the past 90 days.